SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Capital Maintains Stryker at Outperform, Cuts Target to $375

RBC Capital maintained its Outperform rating and lowered its price target on Stryker to $375 from $420.

SYK

Related stories